Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Drug discovery: A helping hand

Nature volume 492, pages 143–145 (2012)Cite this article

Subjects

The pharmaceutical industry is increasingly turning to academics to tackle the early stages of drug discovery.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Trisha Gura is a science writer in Boston, Massachusetts.,

    Trisha Gura

Authors
  1. Trisha Gura
    View author publications

    Search author on:PubMed Google Scholar

Related links

Related links

Related links in Nature Research

A marriage of convenience

Drug buddies

A new method of drug discovery

Industrial endeavours

Enhancing ties between academia and industry to improve health

Pharmaceutical sector: Delicate transition

Naturejobs blog: AstraZeneca cuts R&D jobs

Related external links

National Center for Advancing Translational Sciences

NINDS Office of Translational Research

Institute for Translational Medicine and Therapeutics

US Academic Drug Discovery Consortium

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gura, T. Drug discovery: A helping hand. Nature 492, 143–145 (2012). https://doi.org/10.1038/nj7427-143a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nj7427-143a

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research